Effects of phosphorylcholine coating on extracorporeal circulation management and postoperative outcome: a double-blind randomized study.

The aim of the study was to evaluate the effects of phosphorylcholine coating (PC) on intra-operative extracorporeal circulation (ECC) management and perioperative outcome. One hundred and twenty consecutive cardiac surgery patients were enrolled for the study. Patients were randomly assigned to ECC with PC circuits (60 patients) or to corresponding non-coated circuits (60 patients). Trans-oxygenator pressure drop, blood flows, flow resistances and ECC parameters were recorded at surgery before ECC institution and every 10 min thereafter until ECC discontinuation. Postoperative variables (hematological parameters, drainage blood loss, mechanical ventilation time, incidence of atrial fibrillation, use of blood products) were also assessed and compared between groups. No differences were found between the two groups in terms of demographics, operative, and hematological profiles. PC showed, at equal pump flows, to significantly (P<0.01) attenuate pressure drop across oxygenators and to reduce oxygenator inlet pressures during ECC. Postoperatively, PC showed to remarkably reduce platelet consumption. Coating showed also to reduce postoperative blood loss, although the difference did not reach statistical significance. No differences between the two groups were found in terms of additional perioperative effects. The use of PC in low-risk elective cardiac surgery patients enhances ECC management, by means of a less restrictive trans-oxygenator blood flow.

[1]  D. Mathews Current Transfusion Practices of Members of the American Society of Anesthesiologists: A Survey , 2005 .

[2]  G. Nuttall,et al.  Current Transfusion Practices of Members of the American Society of Anesthesiologists: A Survey , 2003, Anesthesiology.

[3]  J. Laffey,et al.  The Systemic Inflammatory Response to Cardiac Surgery: Implications for the Anesthesiologist , 2002, Anesthesiology.

[4]  J. Arnout,et al.  Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. , 2002, The Journal of thoracic and cardiovascular surgery.

[5]  Von Segesser Lk,et al.  Safety and efficacy of heparin-bonded surfaces in cardiopulmonary bypass. , 2001 .

[6]  D. De Wolf,et al.  Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  C. Brizard,et al.  IL-6 and IL-8 levels after cardiopulmonary bypass are not affected by surface coating. , 1999, The Annals of thoracic surgery.

[8]  L. V. von Segesser,et al.  Pro and con of heparin-bonded circuits for cardiopulmonary bypass. , 1999, Journal of cardiothoracic and vascular anesthesia.

[9]  L. V. von Segesser,et al.  Experimental evaluation of the Dideco D903 Avant 1.7 hollow-fibre membrane oxygenator , 1998, Perfusion.

[10]  D. Birnbaum,et al.  Heparin-coated equipment reduces the risk of oxygenator failure. , 1998, The Annals of thoracic surgery.

[11]  L. Segesser Surface coating of cardiopulmonary bypass circuits. , 1996 .

[12]  L. V. von Segesser,et al.  Surface coating of cardiopulmonary bypass circuits. , 1996, Perfusion.

[13]  M. Blombäck,et al.  Pathologic fibrin formation and cold-induced clotting of membrane oxygenators during cardiopulmonary bypass. , 1995, Journal of cardiothoracic and vascular anesthesia.

[14]  M. Tönz,et al.  Evaluation of Phospholipidic Surface Coatings ex-vivo , 1994, The International journal of artificial organs.

[15]  L. V. von Segesser Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support. , 1996, The Annals of thoracic surgery.

[16]  L. Segesser Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support , 1996 .

[17]  W. Walker,et al.  Physiologic principles and clinical sequelae of cardiopulmonary bypass. , 1986, Heart & lung : the journal of critical care.

[18]  Weiland Ap,et al.  Physiologic principles and clinical sequelae of cardiopulmonary bypass. , 1986 .